BioNexus Gene Lab Corp 10-K filing
Filed 2026-04-14 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001477932-26-002218
- Form type
- 10-K
- CIK
- 0001737523
- Primary document
- https://www.sec.gov/Archives/edgar/data/1737523/000147793226002218/bglc_10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BioNexus Gene Lab Corp.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $7.4M | - | - |
| Cost Of Revenue | $6.3M | - | - |
| Gross Profit | $1.1M | - | - |
| Operating Income | $-3.0M | - | - |
| Net Income | $-3.0M | - | - |
| Cash And Equivalents | $2.5M | - | - |
| Total Assets | $9.3M | - | - |
| Total Liabilities | $637,856 | - | - |
| Shareholders Equity | $8.6M | - | - |
| Operating Cash Flow | $-1.8M | - | - |
| Capital Expenditures | $36,971 | - | - |